Hygeia Healthcare Holdings Co., Ltd. operates as a biopharmaceutical company that focuses on the development of new clinical drugs. It operates through the following segments: Hospital Business, Radiotherapy Business, and Hospital Management Business. The Hospital Business segment operates through self-owned private for-profit hospitals which are variable interest entities owned by the group by undertaking group reorganization. The Radiotherapy Business segment offers licensing of radiotherapy equipment for use in the radiotherapy centres and provision of maintenance and technical support services in relation to radiotherapy equipment. The Hospital Management Business segment engages in provision of management services to private not-for-profit hospitals. The company was founded by Yiwen Zhu in 2009 and is headquartered in Shanghai, China.